Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Chalon, S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 90 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Chalon, S
      Polyunsaturated fatty acids and cognitive functions

      OCL-OLEAGINEUX CORPS GRAS LIPIDES
    2. Emond, P; Helfenbein, J; Chalon, S; Garreau, L; Vercouillie, J; Frangin, Y; Besnard, JC; Guilloteau, D
      Synthesis of tropane and nortropane analogues with phenyl substitutions asserotonin transporter ligands

      BIOORGANIC & MEDICINAL CHEMISTRY
    3. Vancassel, S; Durand, G; Barthelemy, C; Lejeune, B; Martineau, J; Guilloteau, D; Andres, C; Chalon, S
      Plasma fatty acid levels in autistic children

      PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
    4. Vercouillie, J; Tarkiainen, S; Halldin, C; Emond, P; Chalon, S; Sandell, J; Langer, O; Guilloteau, D
      Precursor synthesis and radiolabelling of [C-11]ADAM: A potential radioligand for the serotonin transporter exploration by PET

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    5. Bezard, E; Boraud, T; Chalon, S; Brotchie, JM; Guilloteau, D; Gross, CE
      Pallidal border cells: An anatomical and electrophysiological study in the1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey

      NEUROSCIENCE
    6. Bezard, E; Dovero, S; Prunier, C; Ravenscroft, P; Chalon, S; Guilloteau, D; Crossman, AR; Bioulac, B; Brotchie, JM; Gross, CE
      Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease

      JOURNAL OF NEUROSCIENCE
    7. Prunier, C; Tranquart, F; Cottier, JP; Giraudeau, B; Chalon, S; Guilloteau, D; De Toffol, B; Chossat, F; Autret, A; Besnard, JC; Baulieu, JL
      Quantitative analysis of striatal dopamine D2 receptors with I-123-iodolisuride SPECT in degenerative extrapyramidal diseases

      NUCLEAR MEDICINE COMMUNICATIONS
    8. Chalon, S; Vancassel, S; Zimmer, L; Guilloteau, D; Durand, G
      Polyunsaturated fatty acids and cerebral function: Focus on monoaminergic neurotransmission

      LIPIDS
    9. Cantagrel, S; Gressens, P; Bodard, S; Suc, AL; Laugier, J; Guilloteau, D; Chalon, S
      MRNA D-2 dopaminergic receptor expression after hypoxia-ischemia in rat immature brain

      BIOLOGY OF THE NEONATE
    10. Chalon, S
      N-3 polyunsaturated fatty acids, neurotransmission and cognitive functions

      OCL-OLEAGINEUX CORPS GRAS LIPIDES
    11. Gouhier, C; Chalon, S; Venier-Julienne, MC; Bodard, S; Benoit, JP; Besnard, JC; Guilloteau, D
      Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide

      NEUROSCIENCE LETTERS
    12. Zimmer, L; Delpal, S; Guilloteau, D; Aioun, J; Durand, G; Chalon, S
      Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex

      NEUROSCIENCE LETTERS
    13. Zimmer, L; Kodas, E; Guilloteau, D; Garreau, L; Besnard, JC; Chalon, S
      Microdialysis as a tool for in vivo study of dopamine transporter functionin rat brains

      JOURNAL OF NEUROSCIENCE METHODS
    14. Zimmer, L; Delion-Vancassel, S; Durand, G; Guilloteau, D; Bodard, S; Besnard, JC; Chalon, S
      Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids

      JOURNAL OF LIPID RESEARCH
    15. Chalon, S; Moreno, H; Benowitz, NL; Hoffman, BB; Blaschke, TF
      Nicotine impairs endothelium-dependent dilatation in human veins in vivo

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    16. Tangphao, O; Chalon, S; Coulston, AM; Moreno, H; Chan, JR; Cooke, JP; Hoffman, BB; Blaschke, TF
      L-arginine and nitric oxide-related compounds in plasma: comparison of normal and arginine-free diets in a 24-h crossover study

      VASCULAR MEDICINE
    17. Chalon, S; Berlin, I; Sachon, C; Bosquet, F; Grimaldi, A
      Propranolol in hypoglycaemia unawareness

      DIABETES & METABOLISM
    18. Hall, H; Halldin, C; Guilloteau, D; Chalon, S; Emond, P; Besnard, JC; Farde, L; Sedvall, G
      Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [I-125]PE2I

      NEUROIMAGE
    19. Helfenbein, J; Sandell, J; Halldin, C; Chalon, S; Emond, P; Okubo, Y; Chou, YH; Frangin, Y; Douziech, L; Gareau, L; Swahn, CG; Besnard, JC; Farde, L; Guilloteau, D
      PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter

      NUCLEAR MEDICINE AND BIOLOGY
    20. Chalon, S; Cantagrel, S
      Monoaminergic neurotransmission and brain disorders in newborn and young children

      ARCHIVES DE PEDIATRIE
    21. Chalon, S; Emond, P; Bodard, S; Vilar, MP; Thiercelin, C; Besnard, JC; Guilloteau, D
      Time course of changes in striatal dopamine transporters and D-2 receptorswith specific iodinated markers in a rat model of Parkinson's disease

      SYNAPSE
    22. Helfenbein, J; Emond, P; Loc'h, C; Bottlaender, M; Ottaviani, M; Guilloteau, D; Maziere, B; Frangin, Y; Chalon, S
      Synthesis of (E)-N-(3-bromoprop-2-enyl)-2 beta-carbomethoxy-3 beta-(4 '-tolyl) nortropane (PE2Br) and radiolabelling of [Br-76]PE2Br: A potential ligand for exploration of the dopamine transporter by PET.

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    23. Helfenbein, J; Emond, P; Sandell, J; Halldin, C; Pereyre, S; Frangin, Y; Garreau, L; Besnard, JC; Guilloteau, D; Chalon, S
      Synthesis and radiolabelling of 2 beta-carbomethoxy-3 beta-(3 '-iodo-4 '-isopropylphenyl) nortropane as a radioligand for the exploration of the serotonin transporter by SPET.

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    24. Tangphao, O; Grossmann, M; Chalon, S; Hoffman, BB; Blaschke, TF
      Pharmacokinetics of intravenous and oral L-arginine in normal volunteers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    25. Chalon, S; Tejura, B; Moreno, H; Urae, A; Blaschke, TF; Hoffman, BB
      Role of nitric oxide in isoprenaline and sodium nitroprusside-induced relaxation in human hand veins

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    26. Tangphao, O; Chalon, S; Moreno, H; Hoffman, BB; Blaschke, TF
      Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia

      CLINICAL SCIENCE
    27. Zimmer, L; Durand, G; Guilloteau, D; Chalon, S
      n-3 polyunsaturated fatty acid deficiency and dopamine metabolism in the rat frontal cortex

      LIPIDS
    28. Helfenbein, J; Loc'h, C; Bottlaender, M; Emond, P; Coulon, C; Ottaviani, M; Fuseau, C; Chalon, S; Guenther, I; Besnard, JC; Frangin, Y; Guilloteau, D; Maziere, B
      A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: Pharmacological evaluation and PET experiments

      LIFE SCIENCES
    29. Chalon, S; Garreau, L; Emond, P; Zimmer, L; Vilar, MP; Besnard, JC; Guilloteau, D
      Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2 beta-carboxymethoxy-3 beta-(4 '-methylphenyl)nortropane as a selective and potent inhibitor of the neuronal dopamine transporter

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    30. Tangphao, O; Chalon, S; Moreno, HJ; Abiose, AK; Blaschke, TF; Hoffman, BB
      Heparin-induced vasodilation in human hand veins

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    31. Chalon, S; Moreno, H; Hoffman, BB; Blaschke, TF
      Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    32. Chalon, S; Bedarida, GV; Moreno, H; Tejura, B; Urae, A; Hoffmann, BB; Blaschke, TF
      Inhibition of angiotensin-converting enzyme in human hand veins

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    33. GUILLOTEAU D; EMOND P; BAULIEU JL; GARREAU L; FRANGIN Y; POURCELOT L; MAUCLAIRE L; BESNARD JC; CHALON S
      EXPLORATION OF THE DOPAMINE TRANSPORTER - IN-VITRO AND IN-VIVO CHARACTERIZATION OF A HIGH-AFFINITY AND HIGH-SPECIFICITY IODINATED TROPANE DERIVATIVE TA-CARBOMETHOXY-3-BETA-(4'-METHYLPHENYL)NORTROPANE (PE2I)

      Nuclear medicine and biology
    34. EMOND P; FARDE L; CHALON S; BELZUNG C; MAUCLAIRE V; CHIRON JP; HALLDIN C; BESNARD JC; GUILLOTEAU D
      TOXICITY, MUTAGENICITY, AND BEHAVIORAL-EFFECTS OF BETA-CIT, A LIGAND FOR DOPAMINE TRANSPORTER EXPLORATION BY SPECT

      Nuclear medicine and biology
    35. CHALON S; EMOND P; BESNARD JC; GUILLOTEAU D
      TIME-COURSE OF CHANGES IN THE DOPAMINE TRANSPORTERS AND D-2 RECEPTORSIN A RAT MODEL OF PARKINSONS-DISEASE

      European journal of neuroscience
    36. BELZUNG C; CRETON C; CHALON S; DELIONVANCASSEL S
      EFFECT OF ICV OR INTRA-RAPHE-5 - 7-DIHYDROXYTRYPTAMINE PERFUSION ON STATE AND TRAIT ANXIETY IN BALB C MICE/

      European journal of neuroscience
    37. MORENO H; CHALON S; URAE A; TANGPHAO O; ABIOSE AK; HOFFMAN BB; BLASCHKE TF
      ENDOTHELIAL DYSFUNCTION IN HUMAN HAND VEINS IS RAPIDLY REVERSIBLE AFTER SMOKING CESSATION

      American journal of physiology. Heart and circulatory physiology
    38. KUIKKA JT; BAULIEU JL; HILTUNEN J; HALLDIN C; BERGSTROM KA; FARDE L; EMOND P; CHALON S; YU MX; NIKULA T; LAITINEN T; KARHU J; TUPALA E; HALLIKAINEN T; KOLEHMAINEN V; MAUCLAIRE L; MAZIERE B; TIIHONEN J; GUILLOTEAU D
      PHARMACOKINETICS AND DOSIMETRY OF I-123 LABELED PE2I IN HUMANS, A RADIOLIGAND FOR DOPAMINE TRANSPORTER IMAGING

      European journal of nuclear medicine
    39. ZIMMER L; HEMBERT S; DURAND G; BRETON P; GUILLOTEAU D; BESNARD JC; CHALON S
      CHRONIC N-3 POLYUNSATURATED FATTY-ACID DIET-DEFICIENCY ACTS ON DOPAMINE METABOLISM IN THE RAT FRONTAL-CORTEX - A MICRODIALYSIS STUDY

      Neuroscience letters
    40. HUGUET F; GUERRAOUI A; BARRIER L; GUILLOTEAU D; TALLINEAU C; CHALON S
      CHANGES IN EXCITATORY AMINO-ACID LEVELS AND TISSUE ENERGY METABOLITESOF NEONATE RAT-BRAIN AFTER HYPOXIA AND HYPOXIA-ISCHEMIA

      Neuroscience letters
    41. Page, G; Chalon, S; Barrier, L; Piriou, A; Huguet, F
      Characterization of both dopamine uptake systems in rat striatal slices byspecific pharmacological tools

      NEUROCHEMISTRY INTERNATIONAL
    42. ZIMMER L; EMOND P; FRANGIN Y; CHALON S; BESNARD JC; GUILLOTEAU D
      SPECIFICITY OF PE2I, ANEW COCAINE DERIVATE FOR DOPAMINE TRANSPORTER IMAGING - AN IN-VIVO STUDY BY DUAL-PROBE MICRODIALYSIS

      The Journal of nuclear medicine
    43. HALLDIN C; GUILLOTEAU D; OKUBO Y; LUNDKVIST C; OLSSON H; KARLSSON P; CHALON S; EMOND P; SWAHN CG; FARDE L
      PET-CHARACTERIZATION OF [C-11] PE2I BINDING TO DOPAMINE TRANSPORTER IN THE MONKEY BRAIN

      The Journal of nuclear medicine
    44. SANDELL J; HELFENBEIN J; HALLDIN C; OKUBO Y; CHALON S; FRANGIN Y; GALINIER E; SWAHN CG; GUILLOTEAU D; FARDE L
      PRECURSOR SYNTHESIS, RADIOLABELING AND PET EXAMINATION IN MONKEY OF 3POTENT SEROTONIN TRANSPORTER RADIOLIGANDS

      The Journal of nuclear medicine
    45. HELFENBEIN J; BOTTLAENDER M; COULON C; EDMOND P; OTTAVIANI M; FUSEAU C; CHALON S; LOCH C; FRANGIN Y; GUILLOTEAU D; MAZIERE B
      PHARMACOLOGICAL EVALUATION AND PET STUDIES OF BR-76-PE2BR, A HIGHLY SELECTIVE RADIOBROMINATED COCAINE ANALOG FOR QUANTITATION OF DOPAMINE UPTAKE SITES

      The Journal of nuclear medicine
    46. FAVRELIERE S; BARRIER L; DURAND G; CHALON S; TALLINEAU C
      CHRONIC DIETARY N-3 POLYUNSATURATED FATTY-ACIDS DEFICIENCY AFFECTS THE FATTY-ACID COMPOSITION OF PLASMENYLETHANOLAMINE AND PHOSPHATIDYLETHANOLAMINE DIFFERENTLY IN RAT FRONTAL-CORTEX, STRIATUM, AND CEREBELLUM

      Lipids
    47. BELZUNG C; LEGUISQUET AM; BARREAU S; DELIONVANCASSEL S; CHALON S; DURAND G
      ALPHA-LINOLENIC ACID DEFICIENCY MODIFIES DISTRACTIBILITY BUT NOT ANXIETY AND LOCOMOTION IN RATS DURING AGING

      The Journal of nutrition
    48. Chalon, S; Delion-Vancassel, S; Belzung, C; Guilloteau, D; Leguisquet, AM; Besnard, JC; Durand, G
      Dietary fish oil affects monoaminergic neurotransmission and behavior in rats

      JOURNAL OF NUTRITION
    49. CHALON S; MORENO H; BLASCHKE TF; HOFFMAN BB
      ACE-INHIBITION IMPROVES ENDOTHELIAL FUNCTION IN CHRONIC SMOKERS

      Clinical pharmacology and therapeutics
    50. TANGPHAO O; COULSTON AM; MORENO H; CHALON S; CHAN JR; COOKE JP; BLASCHKE TF; HOFFMAN BB
      DIURNAL-VARIATION OF PLASMA L-ARGININE CONCENTRATIONS AND THE EFFECT OF DIETARY L-ARGININE INTAKE

      Clinical pharmacology and therapeutics
    51. LECHAT P; PACKER M; CHALON S; CUCHERAT M; ARAB T; BOISSEL JP
      CLINICAL EFFECTS OF BETA-ADRENERGIC-BLOCKADE IN CHRONIC HEART-FAILURE- A METAANALYSIS OF DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIALS

      Circulation
    52. EMOND P; CHALON S; GARREAU L; DOGNON AM; BODARD S; FRANGIN Y; BAULIEU JL; BESNARD JC; GUILLOTEAU D
      A NEW IODINATED TROPANE DERIVATIVE (BETA-CDIT) FOR IN-VIVO DOPAMINE TRANSPORTER EXPLORATION - COMPARISON WITH BETA-CIT

      Synapse
    53. EMOND P; BOAZI M; DUCHENE A; CHALON S; BESNARD JC; GUILLOTEAU D; FRANGIN Y
      SYNTHESIS OF IODINATED AND RADIOIODINATED -2-BETA-CARBOMETHOXY-3-BETA-(3',4'-DICHLOROPHENYL) NORTROPANE (BETA-CDIT) - A LIGAND FOR THE DOPAMINE TRANSPORTER

      Journal of labelled compounds & radiopharmaceuticals
    54. RAHALPEROLA V; REVIERS MTH; CHALON S; BODARD S; GUILLOTEAU D; HAMAMAH S; LANSAC J; ROYERE D
      DOES NEONATAL HYPOXIA-ISCHEMIA INFLUENCE MALE REPRODUCTIVE DEVELOPMENT AND FUNCTION

      Human reproduction
    55. CHALON S; EMOND P; THIERCELIN C; BODARD S; GARREAU L; FRANGIN Y; MAUCLAIRE L; BESNARD JC; GUILLOTEAU D
      ROP-2E-ENYL)-2-BETA-CARBOMETHOXY-3-BETA-(4'-METHYL PHENYL) NORTROPANEAS A SELECTIVE MARKER FOR THE DOPAMINE TRANSPORTER - VALIDATION IN A RAT MODEL OF PARKINSONS-DISEASE

      The Journal of nuclear medicine
    56. GUILLOTEAU D; CHALON S; BLAUENSTEIN P; BAULIEU JL; BESNARD JC; SCHUBIGER PA
      MONOAMINE-OXIDASE-B EXPLORATION BY SPET - WHY AND HOW

      The Journal of nuclear medicine
    57. GARREAU L; EMOND P; BELZUNG C; GUILLOTEAU D; FRANGIN Y; BESNARD JC; CHALON S
      RBOMETHOXY-3-BETA-(3',4'-DICHLOROPHENYL)NORTROPANE (BETA-CDIT), A TROPANE DERIVATIVE - PHARMACOLOGICAL CHARACTERIZATION AS A SPECIFIC LIGAND FOR THE DOPAMINE TRANSPORTER IN THE RODENT BRAIN

      The Journal of pharmacology and experimental therapeutics
    58. EMOND P; GARREAU L; CHALON S; BOAZI M; CAILLET M; BRICARD J; FRANGIN Y; MAUCLAIRE L; BESNARD JC; GUILLOTEAU D
      SYNTHESIS AND LIGAND-BINDING OF NORTROPANE DERIVATIVES - N-SUBSTITUTED BETA-CARBOMETHOXY-3-BETA-(4'-IODOPHENYL)NORTROPANE AND L)-2-BETA-CARBOMETHOXY-3-BETA-(3',4'-DISUBSTITUTED PHENYL)NORTROPANE - NEW HIGH-AFFINITY AND SELECTIVE COMPOUNDS FOR THE DOPAMINE TRANSPORTER

      Journal of medicinal chemistry
    59. DELION S; CHALON S; GUILLOTEAU D; LEJEUNE B; BESNARD JC; DURAND G
      AGE-RELATED-CHANGES IN PHOSPHOLIPID FATTY-ACID COMPOSITION AND MONOAMINERGIC NEUROTRANSMISSION IN THE HIPPOCAMPUS OF RATS FED A BALANCED ORAN N-3 POLYUNSATURATED FATTY ACID-DEFICIENT DIET

      Journal of lipid research
    60. PELLEVOISIN C; CHALON S; KUNG HF; BESNARD JC; GUILLOTEAU D
      IS TISCH A SUITABLE TRACER FOR IN-VIVO STUDY OF MODIFICATIONS OF THE DOPAMINE D-1 RECEPTOR

      Nuclear medicine and biology
    61. CHALON S; PELLEVOISIN C; BODARD S; VILAR MP; BESNARD JC; GUILLOTEAU D
      IODINATED PK-11195 AS AN EX-VIVO MARKER OF NEURONAL INJURY IN THE LESIONED RAT-BRAIN

      Synapse
    62. PELLEVOISIN C; GUILLOTEAU D; BAULIEU JL; LOCH C; DOGNON AM; MAUCLAIRE L; SACCAVINI JC; BESNARD JC; CHALON S
      IODALISURIDE AND IODOBENZAMIDE, 2 LIGANDS FOR SPECT EXPLORATION OF THE DOPAMINERGIC D2 RECEPTORS - A COMPARATIVE-STUDY

      Synapse
    63. EMOND P; GARREAU L; CHALON S; BOAZI M; FRANGIN Y; BESNARD JC; GUILLOTEAU D
      THE BETA-CDIT, A NEW COCAINE CONGENER FOR DOPAMINE TRANSPORTER EXPLORATION WITH HIGH SPECIFICITY AND VALUABLE IN-VIVO KINETIC

      The Journal of nuclear medicine
    64. CHALON S; BRUDI P; LECHAT P
      TREATMENT OF ESSENTIAL-HYPERTENSION - ONG OING RANDOMIZED CONTROLLED TRIALS

      Therapie
    65. ZOUAKIA A; GUILLOTEAU D; ZIMMER L; BESNARD JC; CHALON S
      EVOLUTION OF DOPAMINE-RECEPTORS IN THE RAT AFTER NEONATAL HYPOXIA-ISCHEMIA - AUTORADIOGRAPHIC STUDIES

      Life sciences
    66. RAFII H; CHALON S; OMBETTA JE; FRANGIN Y; POURCELOT L; BESNARD JC; BODARD S; GUILLOTEAU D
      AN IODINATED DERIVATIVE OF MOCLOBEMIDE AS POTENTIAL RADIOLIGAND FOR BRAIN MAO-A EXPLORATION

      Life sciences
    67. DELION S; CHALON S; GUILLOTEAU D; BESNARD JC; DURAND G
      ALPHA-LINOLENIC ACID DIETARY DEFICIENCY ALTERS AGE-RELATED-CHANGES OFDOPAMINERGIC AND SEROTONINERGIC NEUROTRANSMISSION IN THE RAT FRONTAL-CORTEX

      Journal of neurochemistry
    68. LECHAT PP; CHALON S; CUCHERAT M; PACKER M; BOISSEL JP
      METAANALYSIS OF RANDOMIZED CLINICAL-TRIALS ON BETA-BLOCKER TREATMENT IN HEART-FAILURE

      Circulation
    69. CHALON S; LECHAT P
      ANTITHROMBOTIC TREATMENT IN ATRIAL-FIBRIL LATION

      Archives des maladies du coeur et des vaisseaux
    70. LENA I; OMBETTA JE; CHALON S; DOGNON AM; BAULIEU JL; FRANGIN Y; GARREAU L; BESNARD JC; GUILLOTEAU D
      IODODERIVATIVE OF PARGYLINE - A POTENTIAL TRACER FOR THE EXPLORATION OF MONOAMINE-OXIDASE SITES BY SPECT

      Nuclear medicine and biology
    71. RAFII H; CHALON S; OMBETTA JE; FRANGIN Y; GARREAU L; DOGNON AM; LENA I; BODARD S; VILAR MP; BESNARD JC; GUILLOTEAU D
      SYNTHESIS AND CHARACTERIZATION OF [I-125] N-(2-AMINOETHYL)-4-IODOBENZAMIDE SELECTIVE AS A MONOAMINE-OXIDASE-B INHIBITOR

      Nuclear medicine and biology
    72. BRANGER C; GARREAU L; DOGNON AM; FRANGIN Y; CAILLET M; OMBETTAGOKA JE; CHALON S; BESNARD JC; GUILLOTEAU D
      SYNTHESIS OF 4'-IODO-5-METHOXY-VALEROPHENONE O-(2-AMINOETHYL)OXIME ASAN AGENT FOR EXPLORATION OF SEROTONINERGIC TRANSPORTER

      Nuclear medicine and biology
    73. BRANGER C; GARREAU L; FRANGIN Y; CHALON S; DUBOIS P; DOGNON AM; OMBETTAGOKA JE; BESNARD JC; GUILLOTEAU D
      RADIOIODINATED ANALOGS OF XYLAMINE - N-(2-CHLOROETHYL)-N-ETHYL-2-[I-125]IODOBENZYLAMINE AND N,N-DIETHYL-2-[I-125]IODOBENZYLAMINE AS POTENTIAL TOOLS FOR MONOAMINE UPTAKE EXPLORATION BY SPECT

      Journal of labelled compounds & radiopharmaceuticals
    74. POUSSET F; CHALON S; THOMARE P; DIQUET B; LECHAT P
      EVALUATION OF CARDIAC BETA(1)-ADRENERGIC SENSITIVITY WITH DOBUTAMINE IN HEALTHY-VOLUNTEERS

      British journal of clinical pharmacology
    75. BERLIN I; CHALON S; PAYAN C; SCHOLLNHAMMER G; CESSELIN F; VAROQUAUX O; PUECH AJ
      EVALUATION OF THE ALPHA(2)-ADRENOCEPTOR BLOCKING PROPERTIES OF BUSPIRONE AND IPSAPIRONE IN HEALTHY-SUBJECTS - RELATIONSHIP WITH THE PLASMA-CONCENTRATION OF THE COMMON METABOLITE 1-(2-PYRIMIDINYL)-PIPERAZINE

      British journal of clinical pharmacology
    76. DEMOLIS P; CHALON S; GIUDICELLI JF
      ACETAZOLAMIDE-INDUCED VASODILATION IN THE CAROTID VASCULAR BED IN HEALTHY-VOLUNTEERS

      Journal of cardiovascular pharmacology
    77. CHALON S; BRUDI P; LECHAT P
      RESULTS OF CLINICAL-TRIALS ON REDUCTION O F HOLTER RECORDED MYOCARDIAL-ISCHEMIA

      Therapie
    78. CHALON S; ZOUAKIA A; SALIBA E; ZIMMER L; BESNARD JC; GUILLOTEAU D
      EVOLUTION OF STRIATAL DOPAMINE-RECEPTORS AFTER A NEONATAL HYPOXIC-ISCHEMIC INJURY IN THE RAT

      Pediatric research
    79. SALIBA E; HUGUET F; CHALON S; TALLINEAU C; PIRIOU A; LAUGIER J
      DIHYDROPYRIDINE (DHP) BINDING-SITES CHARACTERISTICS IN THE BRAIN OF NEWBORN PIGLETS FOLLOWING HYPOXIA AND ISCHEMIA (HI)

      Pediatric research
    80. ZOUAKIA A; CHALON S; KUNG HF; DOGNON AM; SALIBA E; BESNARD JC; GUILLOTEAU D
      RADIOIODINATED TRACERS FOR THE EVALUATION OF DOPAMINE-RECEPTORS IN THE NEONATAL RAT-BRAIN AFTER HYPOXIC-ISCHEMIC INJURY

      European journal of nuclear medicine
    81. GARREAU L; OMBETTA JE; GALINIER E; DOGNON AM; CHALON S; FRANGIN Y; BESNARD JC; GUILLOTEAU D
      NEW RADIOLIGANDS FOR THE EXPLORATION OF DOPAMINE UPTAKE SITES BY SPET- DEVELOPMENT OF DERIVATIVES OF MAZINDOL - STRUCTURE AFFINITY RELATIONSHIP

      The Journal of nuclear medicine
    82. GUILLOTEAU D; PELLEVOISIN C; CHALON S; MAZIERE B; SACCAVINI JC; BESNARD JC
      COMPARISON OF 3 SPECIFIC D2 DOPAMINE-RECEPTOR RADIOIODINATED LIGANDS IN ANIMAL-MODELS OF QUANTITATIVE RECEPTOR ALTERATIONS

      The Journal of nuclear medicine
    83. SALIBA E; CHALON S; LAUGIER J
      EFFECT OF HYPOXIC-ISCHEMIC (H-I) BRAIN-DAMAGE ON GLUTAMATE RELEASE AND D1 MARKERS IN THE NEWBORN PIGLET

      Pediatric research
    84. DELION S; CHALON S; HERAULT J; GUILLOTEAU D; BESNARD JC; DURAND G
      CHRONIC DIETARY ALPHA-LINOLENIC ACID DEFICIENCY ALTERS DOPAMINERGIC AND SEROTONINERGIC NEUROTRANSMISSION IN RATS

      The Journal of nutrition
    85. BERLIN I; ROSENZWEIG P; CHALON S; FUSEAU E; LANDAULT C; CESSELIN F; BLACKER C; PUECH AJ
      REDUCTION OF HYPERGLYCEMIA AFTER ORAL GLUCOSE-LOAD BY THE NEW ALPHA(2)-ADRENERGIC RECEPTOR ANTAGONIST SL84.0418 IN HEALTHY-SUBJECTS

      Clinical pharmacology and therapeutics
    86. GALINIER E; GARREAU L; DOGNON AM; OMBETTAGOKA JE; FRANGIN Y; CHALON S; BESNARD JC; GUILLOTEAU D
      SYNTHESIS OF HALOGENATED ANALOGS OF -2,3-DIHYDRO-5-HYDROXY-5H-IMIDAZO[2,1-A]-ISOINDOLE OR MAZINDOL FOR EXPLORATION OF THE DOPAMINE TRANSPORTER

      European journal of medicinal chemistry
    87. DEMOLIS P; CHALON S; GUIDICELLI JF
      REPEATABILITY TESTING FOR TRANSCRANIAL DOPPLER SONOGRAPHY - REPLY

      Clinical science
    88. DEMOLIS P; CHALON S; GIUDICELLI JF
      REPEATABILITY OF TRANSCRANIAL DOPPLER MEASUREMENTS OF ARTERIAL BLOOD-FLOW VELOCITIES IN HEALTHY-SUBJECTS

      Clinical science
    89. PELLEVOISIN C; CHALON S; ZOUAKIA A; DOGNON AM; FRANGIN Y; BAULIEU JL; BESNARD JC; GUILLOTEAU D
      COMPARISON OF 2 RADIOIODINATED LIGANDS OF DOPAMINE-D2 RECEPTORS IN ANIMAL-MODELS - IODOBENZAMIDE AND IODOETHYLSPIPERONE

      Life sciences
    90. PELLEVOISIN C; CHALON S; GUILLOTEAU D; BESNARD JC
      DIFFERENTIAL CHANGES IN STRIATAL D1 AND D2 DOPAMINE-RECEPTORS AFTER EXCITOTOXIN-INDUCED LESIONS IN RATS

      Journal of neurochemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 12:00:11